Carl Icahn sells Tropicana casinos in $1.85 billion deal
April 16, 2018
Futures rise on hope Syria conflict will not escalate
April 16, 2018

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

LONDON (Reuters) – Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.

Powered by WPeMatico